Prenatal diagnosis of hydrancephaly and enlarged cerebellum and cisterna magna in a fetus with thanatophoric dysplasia type II and a review of prenatal diagnosis of brain anomalies associated with thanatophoric dysplasia

Taiwan J Obstet Gynecol. 2018 Feb;57(1):119-122. doi: 10.1016/j.tjog.2017.12.020.

Abstract

Objective: We present prenatal diagnosis of hydrancephaly and enlarged cerebellum and cisterna magna in a fetus with thanatophoric dysplasia type II (TD2) and a review of prenatal diagnosis of brain anomalies associated with TD.

Case report: A 33-year-old woman was referred for genetic counseling at 25 weeks of gestation because of fetal ultrasound abnormalities. Prenatal ultrasound at 14 weeks of gestation revealed an increased nuchal translucency (NT) and hydrocephalus. Level II ultrasound examination at 25 weeks of gestation revealed hydrancephaly, macrocephaly, a cloverleaf skull, frontal bossing, enlarged cerebellum and cisterna magna, a narrow chest, small ribs, short straight limbs. Amniocentesis revealed a karyotype of 46,XX. FGFR3 mutation analysis using the DNA extracted from uncultured amniocytes revealed a genotype of WT/c.1948A>G (p.Lys650Glu). The result was consistent with a K650E mutation in FGFR3 and TD2. The pregnancy was subsequently terminated.

Conclusion: Fetuses with TD2 may present increased NT, early onset hydrocephalus, enlarged cerebellum and cisterna magna, and hydrancephaly on prenatal ultrasound.

Keywords: Brain anomalies; Hydrancephaly; Prenatal diagnosis; Thanatophoric dysplasia type II.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Amniocentesis / methods
  • Cerebellum / abnormalities*
  • Cerebellum / diagnostic imaging
  • Cisterna Magna / diagnostic imaging*
  • DNA Mutational Analysis
  • Female
  • Humans
  • Hydranencephaly / diagnostic imaging*
  • Karyotype
  • Mutation
  • Pregnancy
  • Receptor, Fibroblast Growth Factor, Type 3 / genetics
  • Skull / abnormalities*
  • Skull / diagnostic imaging
  • Thanatophoric Dysplasia / diagnostic imaging*
  • Ultrasonography, Prenatal / methods*

Substances

  • FGFR3 protein, human
  • Receptor, Fibroblast Growth Factor, Type 3

Supplementary concepts

  • Thanatophoric dysplasia, type 2